Bioxytran Inc. Invited to New York Venture Summit
BOSTON, MASSACHUSETTS, July 09, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to treat stroke victims announced today that it was invited to attend the 19th annual New York Venture Summit, presented by youngStartup Ventures on July 9th and July 10th. The summit is being held at the Convene meeting center in New York City.
July 12, 2019